OrganoClick (ORGC) ABGSC Investor Days summary
Event summary combining transcript, slides, and related documents.
ABGSC Investor Days summary
11 Jan, 2026Company overview and mission
Focuses on replacing fossil plastics and hazardous chemicals with bio-based solutions using biomimicry and cellulose modification technology.
Operates in three main business areas: nonwovens, textile waterproofing, and wood protection.
Uses biopolymers from food waste for binders, natural fatty compounds for waterproofing, and minerals for wood protection.
Listed on Nasdaq First North since 2015, with headquarters and R&D in Täby and a 20,000-ton annual production capacity.
Exports to 20 markets and has received multiple innovation and sustainability awards.
Business segments and market position
Nonwovens: Supplies bio-based binders to industrial customers, with Duni as a major client; products are used in napkins, hygiene products, and packaging.
Textile waterproofing: OrganoTex is the leading brand in Sweden and the Netherlands, with over 500 resellers and high double-digit growth.
Wood protection: Collaborates with Bergs Timber and is expanding to new international partners; recent product launch offers termite resistance.
Consumer products have higher margins than industrial products, driving overall profitability.
Product mix and increased volumes are expected to further improve gross margins, targeting 40% long-term.
Financial performance and scalability
Achieved SEK 146 million in revenue last year, up 27% year-over-year, with an average 20% annual growth since listing.
Factory produced 4,000 tons last year, with significant unused capacity for scaling without major new investments.
Cash flow from operating activities turned positive, reaching SEK 6 million for the 12 months to September 2024.
EBIT is near break-even, with improved gross margins despite a challenging year in construction and nonwovens.
Focus for 2025 is on sales growth and profitability, especially in OrganoTex and nonwovens.
Latest events from OrganoClick
- Sales fell sharply and losses deepened, but cost cuts aim to restore profitability in 2026.ORGC
Q4 202512 Feb 2026 - Sales fell 22% in Q3, but cost cuts and new financing target improved 2026 results.ORGC
Q3 20255 Nov 2025 - Q2 2025 sales dropped 22.7% year-over-year, with losses widening and new funding secured.ORGC
Q2 202518 Jul 2025 - Consumer brands grew 24% in Q3, but overall sales declined and leverage increased.ORGC
Q3 202413 Jun 2025 - Gross margin rose to 29.1% as EBIT neared breakeven despite a 5.6% sales decline.ORGC
Q2 202413 Jun 2025 - Biobased innovation drives OrganoClick's growth and expansion in European markets.ORGC
ABGSC Investor Days6 Jun 2025 - Sales fell 7.3% as industrial headwinds persisted, but consumer brands expanded retail reach.ORGC
Q1 20256 Jun 2025 - Consumer brands grew over 30% as industrial sales fell, but cash flow improved in 2024.ORGC
Q4 20245 Jun 2025